Clinical Trial Update: A Study to Evaluate Efficacy and Safety of Zolpidem Modified Release Formulation in Insomnia Patients [Phase 4]

View source ↗

Summary

A Phase 4 study evaluating the efficacy and safety of a zolpidem modified-release formulation for insomnia has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Insomnia

Drugs mentioned

• Zolpidem Modified Release Formulation (zolpidem)

Snippet

Sponsor: Astellas Pharma Inc | Conditions: Sleep Initiation and Maintenance Disorders, Primary Insomnia | Phase 4 | Status: COMPLETED